scholarly journals Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study

2016 ◽  
Vol 30 (10) ◽  
pp. 1753-1759 ◽  
Author(s):  
F. Valenzuela ◽  
C. Paul ◽  
L. Mallbris ◽  
H. Tan ◽  
J. Papacharalambous ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Psoriasis Patient ◽  
Chronic Plaque Psoriasis ◽  
Phase 3 ◽  
Patient Reported

25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials

2021 ◽  
Vol 85 (3) ◽  
pp. AB71
Author(s):  
Robert Bissonnette ◽  
Bruce Strober ◽  
Mark Lebwohl ◽  
Jerry Bagel ◽  
James Del Rosso ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Psoriasis Patient ◽  
Phase 3 ◽  
Pivotal Phase ◽  
Once Daily ◽  
Patient Reported

Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)

2017 ◽  
Vol 1 ◽  
pp. s4 ◽  
Author(s):  
Diamant Thaci ◽  
Alice Gottlieb ◽  
Kristian Reich ◽  
Jerry Bagel ◽  
Daniel Burge ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Certolizumab Pegol ◽  
Chronic Plaque Psoriasis ◽  
Phase 3 ◽  
Patient Reported ◽  
Ongoing Phase

Abstract Not Available Disclosure: Study supported by Dermira.

27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis

2021 ◽  
Vol 85 (3) ◽  
pp. AB164
Author(s):  
Linda Stein Gold ◽  
Javier Alonso-Llamazares ◽  
Zoe D. Draelos ◽  
Melinda J. Gooderham ◽  
Steven E. Kempers ◽  
...  
Keyword(s):  
Disease Severity ◽  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Chronic Plaque Psoriasis ◽  
Patient Reported

Patient-reported outcomes in subjects with plaque psoriasis treated with tapinarof cream: Results from a phase 2b, randomized parallel-group study

2018 ◽  
Vol 2 ◽  
pp. S85
Author(s):  
Neal Bhatia ◽  
David Rubenstein ◽  
Anna M Tallman ◽  
James Lee
Keyword(s):  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Parallel Group Study ◽  
Parallel Group ◽  
Patient Reported

Abstract not available. Disclosures: Study sponsored by Dermavant.Copyright 2018 SKIN

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle-Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

2017 ◽  
Vol 1 ◽  
pp. s96
Author(s):  
David M Pariser ◽  
Adelaide A Hebert ◽  
Janice Drew ◽  
John Quiring ◽  
Dee Anna Glaser
Keyword(s):  
Patient Reported Outcomes ◽  
Axillary Hyperhidrosis ◽  
Phase 3 ◽  
Double Blind ◽  
Patient Reported

Abstract Not AvailableDisclosure: Study supported by Dermira.

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

2018 ◽  
Vol 2 ◽  
pp. S41
Author(s):  
David M Pariser ◽  
Adelaide A Hebert ◽  
Janice Drew ◽  
John Quiring ◽  
Dee Anna Glaser
Keyword(s):  
Patient Reported Outcomes ◽  
Axillary Hyperhidrosis ◽  
Phase 3 ◽  
Double Blind ◽  
Patient Reported

Abstract not available. Disclosures: Study supported by Dermira. Copyright SKIN 2018

Sign in / Sign up

Export Citation Format

Share Document